There were 353 press releases posted in the last 24 hours and 431,662 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Altimmune Submits Investigational New Drug Application for NasoVAX in Preparation for Phase 2 Trial

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image